Research ExplorerScientific StaffKatja Weisel Publications

Prof.Dr.med. ID: 6488383

Katja Weisel

graph of relations
Affiliations
1 - 50 out of 244Page size: 50

Publications

  1. 2004

  2. Intravascular lymphoma - a rare cause of hemolytic anemia and neurologic disorders

    Weisel, K. C., Brugger, W., Kröber, S. M., Kaiserling, E. & Kanz, L., 2004, In: HEMATOL J. 5, 5, p. 444-6 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. Elevated telomerase activity and minimal telomere loss in cord blood long-term cultures with extensive stem cell replication

    Gammaitoni, L., Weisel, K. C., Gunetti, M., Wu, K-D., Bruno, S., Pinelli, S., Bonati, A., Aglietta, M., Moore, M. A. S. & Piacibello, W., 15.06.2004, In: BLOOD. 103, 12, p. 4440-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  4. 2005

  5. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells V, University of Tübingen, Germany, September 16-18, 2004

    Weisel, K. C., Brümmendorf, T. H., Orlic, D., Fibbe, W. E. & Kanz, L., 05.2005, In: Experimental hematology. 33, 5, p. 513-22 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  6. Genetic and functional characterization of isolated stromal cell lines from the aorta-gonado-mesonephros region

    Weisel, K. C. & Moore, M. A. S., 06.2005, In: ANN NY ACAD SCI. 1044, p. 51-9 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  7. 2006

  8. Stromal cell lines from the aorta-gonado-mesonephros region are potent supporters of murine and human hematopoiesis

    Weisel, K. C., Gao, Y., Shieh, J-H. & Moore, M. A. S., 11.2006, In: Experimental hematology. 34, 11, p. 1505-16 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Progressive bicytopenia due to persistent parvovirus B19 infection after immunochemotherapy with fludarabine/cyclophosphamide and rituximab for relapsed B cell lymphoma

    Hartmann, J. T., Meisinger, I., Kröber, S. M., Weisel, K., Klingel, K. & Kanz, L., 12.2006, In: HAEMATOLOGICA. 91, 12 Suppl, p. ECR49

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2007

  11. Differential effects of G protein coupled receptors on hematopoietic progenitor cell growth depend on their signaling capacities

    Xue, X., Cai, Z., Seitz, G., Kanz, L., Weisel, K. C. & Möhle, R., 06.2007, In: ANN NY ACAD SCI. 1106, p. 180-9 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  12. Effect of FLT3 inhibition on normal hematopoietic progenitor cells

    Weisel, K. C., Yildirim, S., Schweikle, E., Kanz, L. & Möhle, R., 06.2007, In: ANN NY ACAD SCI. 1106, p. 190-6 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  13. Meeting summary: International Symposium and Workshop on Hematopoietic Stem Cells VI, University of Tübingen, Germany, September 14-16, 2006

    Weisel, K. C., Fibbe, W. E. & Kanz, L., 07.2007, In: Experimental hematology. 35, 7, p. 1005-14 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research

  14. 2008

  15. European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial

    Hutchison, C. A., Cook, M., Heyne, N., Weisel, K., Billingham, L., Bradwell, A. & Cockwell, P., 28.09.2008, In: TRIALS. 9, p. 55

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  16. OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells

    Ji, J., Vijayaragavan, K., Bosse, M., Menendez, P., Weisel, K. & Bhatia, M., 10.2008, In: Stem cells (Dayton, Ohio). 26, 10, p. 2485-95 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Epstein-Barr virus-associated B-cell lymphoma secondary to FCD-C therapy in patients with peripheral T-cell lymphoma

    Weisel, K. C., Weidmann, E., Anagnostopoulos, I., Kanz, L., Pezzutto, A. & Subklewe, M., 11.2008, In: International journal of hematology. 88, 4, p. 434-440 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. 2009

  19. Modulation of CXC chemokine receptor expression and function in human neutrophils during aging in vitro suggests a role in their clearance from circulation

    Weisel, K. C., Bautz, F., Seitz, G., Yildirim, S., Kanz, L. & Möhle, R., 2009, In: MEDIAT INFLAMM. 2009, p. 790174

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Development of rapid light-chain deposition disease in hepatic arteries with severe ischemic cholangitis in a multiple myeloma patient treated with melphalan, prednisone and lenalidomide

    Weisel, K. C., Böckeler, M., Bianchi, L., Terracciano, L. M., Mayer, F. & Kanz, L., 01.2009, In: International journal of hematology. 89, 1, p. 91-94 4 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Extended in vitro expansion of adult, mobilized CD34+ cells without significant cell senescence using a stromal cell coculture system with single cytokine support

    Weisel, K. C., Moore, M. A. S., Kanz, L. & Möhle, R., 03.2009, In: STEM CELLS DEV. 18, 2, p. 229-34 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. Regulation of FLT3 and its ligand in normal hematopoietic progenitor cells

    Weisel, K. C., Yildirim, S., Schweikle, E., Kanz, L. & Möhle, R., 03.2009, In: ANN HEMATOL. 88, 3, p. 203-11 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Contamination of autologous peripheral blood progenitor cell grafts predicts overall survival after high-dose chemotherapy in multiple myeloma

    Kopp, H. G., Yildirim, S., Weisel, K. C., Kanz, L. & Vogel, W., 04.2009, In: J CANCER RES CLIN. 135, 4, p. 637-42 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. International Symposium and Workshop on hematopoietic stem cells VII, University of Tübingen, Germany, September 18-20, 2008

    Weisel, K. C., Dick, J., Fibbe, W. E. & Kanz, L., 09.2009, In: ANN NY ACAD SCI. 1176, p. 1-17 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. Pathologic fractures in patients with multiple myeloma undergoing bisphosphonate therapy: incidence and correlation with course of disease

    Vogel, M. N., Weisel, K., Maksimovic, O., Peters, S., Brodoefel, H., Claussen, C. D. & Horger, M. S., 09.2009, In: AM J ROENTGENOL. 193, 3, p. 656-61 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  26. Rhabdomyolysis and acute kidney injury

    Heyne, N., Guthoff, M. & Weisel, K. C., 01.10.2009, In: NEW ENGL J MED. 361, 14, p. 1412; author reply 1412-3

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. DSMM XI study: dose definition for intravenous cyclophosphamide in combination with bortezomib/dexamethasone for remission induction in patients with newly diagnosed myeloma

    Kropff, M., Liebisch, P., Knop, S., Weisel, K., Wand, H., Gann, C-N., Berdel, W. E., Einsele, H. & Deutsche Studiengruppe Multiples Myelom, DSMM, 11.2009, In: ANN HEMATOL. 88, 11, p. 1125-30 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  28. Severe psychotic disorder and agranulocytosis--a therapeutic dilemma

    Borbé, R., Weisel, K., Sachs, U. J. H. & Steinert, T., 11.2009, In: PHARMACOPSYCHIATRY. 42, 6, p. 284-5 2 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. 2010

  30. A phase II study of alemtuzumab, fludarabine, cyclophosphamide, and doxorubicin (Campath-FCD) in peripheral T-cell lymphomas

    Weidmann, E., Hess, G., Chow, K. U., Krause, S. W., Subklewe, M., Kruse, J., Weisel, K. C., Soekler, M., Kim, S-Z., Napieralski, S., Rech, J., Dreyling, M., Jäger, E. & Mitrou, P. S., 03.2010, In: LEUKEMIA LYMPHOMA. 51, 3, p. 447-55 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Wnt1 overexpression leads to enforced cardiomyogenesis and inhibition of hematopoiesis in murine embryonic stem cells

    Weisel, K. C., Kopp, H-G., Moore, M. A. S., Studer, L. & Barberi, T., 05.2010, In: STEM CELLS DEV. 19, 5, p. 745-51 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. Imaging findings in relapsing multiple myeloma

    Sauter, A., Weisel, K. & Horger, M., 08.2010, In: BRIT J HAEMATOL. 150, 4, p. 388

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  33. Response assessment in patients with multiple myeloma during antiangiogenic therapy using arterial spin labeling and diffusion-weighted imaging: a feasibility study

    Fenchel, M., Konaktchieva, M., Weisel, K., Kraus, S., Claussen, C. D. & Horger, M., 11.2010, In: ACAD RADIOL. 17, 11, p. 1326-33 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. Early response assessment in patients with multiple myeloma during anti-angiogenic therapy using arterial spin labelling: first clinical results

    Fenchel, M., Konaktchieva, M., Weisel, K., Kraus, S., Brodoefel, H., Claussen, C. D. & Horger, M., 12.2010, In: EUR RADIOL. 20, 12, p. 2899-906 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  35. 2011

  36. Whole-body diffusion-weighted MRI with apparent diffusion coefficient mapping for early response monitoring in multiple myeloma: preliminary results

    Horger, M., Weisel, K., Horger, W., Mroue, A., Fenchel, M. & Lichy, M., 06.2011, In: AM J ROENTGENOL. 196, 6, p. W790-5

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Modern imaging techniques during therapy in patients with multiple myeloma

    Horger, M., Weisel, K., Bares, R., Ernemann, U., Claussen, C. D., Lichy, M. & Fenchel, M., 01.10.2011, In: ACTA RADIOL. 52, 8, p. 881-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  38. 2012

  39. Can whole-body low-dose multidetector CT exclude the presence of myeloma bone disease in patients with monoclonal gammopathy of undetermined significance (MGUS)?

    Spira, D., Weisel, K., Brodoefel, H., Schulze, M., Kaufmann, S. & Horger, M., 01.2012, In: ACAD RADIOL. 19, 1, p. 89-94 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Osteoprotegerin positively regulates hematopoietic progenitor cells

    Schweikle, E., Baessler, T., Yildirim, S., Kanz, L., Möhle, R. & Weisel, K. C., 01.2012, In: CURR STEM CELL RES T. 7, 1, p. 72-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. Administration of bortezomib before and after autologous stem cell transplantation improves outcome in multiple myeloma patients with deletion 17p

    Neben, K., Lokhorst, H. M., Jauch, A., Bertsch, U., Hielscher, T., van der Holt, B., Salwender, H., Blau, I. W., Weisel, K., Pfreundschuh, M., Scheid, C., Dührsen, U., Lindemann, W., Schmidt-Wolf, I. G. H., Peter, N., Teschendorf, C., Martin, H., Haenel, M., Derigs, H. G., Raab, M. S., Ho, A. D., van de Velde, H., Hose, D., Sonneveld, P. & Goldschmidt, H., 26.01.2012, In: BLOOD. 119, 4, p. 940-8 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  42. Extracorporeal light chain elimination: high cut-off (HCO) hemodialysis parallel to chemotherapy allows for a high proportion of renal recovery in multiple myeloma patients with dialysis-dependent acute kidney injury

    Heyne, N., Denecke, B., Guthoff, M., Oehrlein, K., Kanz, L., Häring, H-U. & Weisel, K. C., 05.2012, In: ANN HEMATOL. 91, 5, p. 729-735 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Continuous lenalidomide treatment for newly diagnosed multiple myeloma

    Palumbo, A., Hajek, R., Delforge, M., Kropff, M., Petrucci, M. T., Catalano, J., Gisslinger, H., Wiktor-Jędrzejczak, W., Zodelava, M., Weisel, K., Cascavilla, N., Iosava, G., Cavo, M., Kloczko, J., Bladé, J., Beksac, M., Spicka, I., Plesner, T., Radke, J., Langer, C., Ben Yehuda, D., Corso, A., Herbein, L., Yu, Z., Mei, J., Jacques, C., Dimopoulos, M. A. & MM-015 Investigators, 10.05.2012, In: NEW ENGL J MED. 366, 19, p. 1759-69 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  44. Proteasome inhibition by bortezomib: effect on HLA-antibody levels and specificity in sensitized patients awaiting renal allograft transplantation

    Guthoff, M., Schmid-Horch, B., Weisel, K. C., Häring, H-U., Königsrainer, A. & Heyne, N., 06.2012, In: TRANSPL IMMUNOL. 26, 4, p. 171-5 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Successful treatment of patients with multiple myeloma and impaired renal function with lenalidomide: results of 4 German centers

    Oehrlein, K., Langer, C., Sturm, I., Pönisch, W., Hahn-Ast, C., Kuhn, S. & Weisel, K. C., 06.2012, In: CL LYMPH MYELOM LEUK. 12, 3, p. 191-6 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma

    Auel, B., Goldschmidt, H., Geer, T., Moehler, T. M., Platzbecker, U., Naumann, R., Blau, I., Hänel, M., Knauf, W., Nückel, H., Salwender, H-J., Scheid, C., Weisel, K., Gorschlüter, M., Glasmacher, A., Schmidt-Wolf, I. G. H. & German Refractory Myeloma Study Group, 06.2012, In: INDIAN J HEMATOL BLO. 28, 2, p. 67-76 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trial

    Sonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., El Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Vellenga, E., Broyl, A., Blau, I. W., Weisel, K. C., Wittebol, S., Bos, G. M. J., Stevens-Kroef, M., Scheid, C., Pfreundschuh, M., Hose, D., Jauch, A., van der Velde, H., Raymakers, R., Schaafsma, M. R., Kersten, M-J., van Marwijk-Kooy, M., Duehrsen, U., Lindemann, W., Wijermans, P. W., Lokhorst, H. M. & Goldschmidt, H. M., 20.08.2012, In: J CLIN ONCOL. 30, 24, p. 2946-55 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. 2013

  49. Cutaneous presentation of hematological malignancies

    Eberle, F. C., Metzler, G., Weisel, K. C., Berneburg, M. & Yazdi, A. S., 21.06.2013, In: EUR J DERMATOL. 23, 3, p. 372-7 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  50. The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomas

    Adam, P., Baumann, R., Schmidt, J., Bettio, S., Weisel, K., Bonzheim, I., Fend, F. & Quintanilla-Martínez, L., 09.2013, In: HUM PATHOL. 44, 9, p. 1817-26 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial

    Miguel, J. S., Weisel, K., Moreau, P., Lacy, M., Song, K., Delforge, M., Karlin, L., Goldschmidt, H., Banos, A., Oriol, A., Alegre, A., Chen, C., Cavo, M., Garderet, L., Ivanova, V., Martinez-Lopez, J., Belch, A., Palumbo, A., Schey, S., Sonneveld, P., Yu, X., Sternas, L., Jacques, C., Zaki, M. & Dimopoulos, M., 10.2013, In: LANCET ONCOL. 14, 11, p. 1055-1066 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. Role of dynamic contrast-enhanced sonography for characterization and monitoring of extramedullary myeloma: comparison with serologic data

    Pintoffl, J. P., Weisel, K., Schulze, M., Maksimovic, O., Claussen, C. D., Kramer, U. & Horger, M., 10.2013, In: J ULTRAS MED. 32, 10, p. 1777-88 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. 2014

  54. Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial

    Scheid, C., Sonneveld, P., Schmidt-Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H., Zweegman, S., Blau, I. W., Vellenga, E., Weisel, K., Pfreundschuh, M., Jie, K-S., Neben, K., van de Velde, H., Duehrsen, U., Schaafsma, M. R., Lindemann, W., Kersten, M. J., Peter, N., Hänel, M., Croockewit, S., Martin, H., Wittebol, S., Bos, G. M., van Marwijk-Kooy, M., Wijermans, P., Goldschmidt, H. & Lokhorst, H. M., 01.2014, In: HAEMATOLOGICA. 99, 1, p. 148-54 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  55. Increasing bone sclerosis during bortezomib therapy in multiple myeloma patients: results of a reduced-dose whole-body MDCT study

    Schulze, M., Weisel, K., Grandjean, C., Oehrlein, K., Zago, M., Spira, D. & Horger, M., 01.2014, In: AM J ROENTGENOL. 202, 1, p. 170-9 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide era

    Zago, M., Adam, P., Goldschmidt, H., Fend, F., Kanz, L. & Weisel, K., 02.2014, In: CL LYMPH MYELOM LEUK. 14, 1, p. e7-e11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. Paraneoplastic granulocyte colony-stimulating factor secretion in soft tissue sarcoma mimicking myeloproliferative neoplasia: a case report

    Dorn, C., Bugl, S., Malenke, E., Müller, M. R., Weisel, K. C., Vogel, U., Horger, M., Kanz, L. & Kopp, H-G., 23.05.2014, In: BMC RES NOTES. 7, p. 313

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  58. Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myeloma

    Dimopoulos, M. A., Leleu, X., Palumbo, A., Moreau, P., Delforge, M., Cavo, M., Ludwig, H., Morgan, G. J., Davies, F. E., Sonneveld, P., Schey, S. A., Zweegman, S., Hansson, M., Weisel, K., Mateos, M. V., Facon, T. & Miguel, J. F. S., 08.2014, In: LEUKEMIA. 28, 8, p. 1573-85 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  59. Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

    Benboubker, L., Dimopoulos, M. A., Dispenzieri, A., Catalano, J., Belch, A. R., Cavo, M., Pinto, A., Weisel, K., Ludwig, H., Bahlis, N., Banos, A., Tiab, M., Delforge, M., Cavenagh, J., Geraldes, C., Lee, J-J., Chen, C., Oriol, A., de la Rubia, J., Qiu, L., White, D. J., Binder, D., Anderson, K., Fermand, J-P., Moreau, P., Attal, M., Knight, R., Chen, G., Van Oostendorp, J., Jacques, C., Ervin-Haynes, A., Avet-Loiseau, H., Hulin, C., Facon, T. & FIRST Trial Team, 04.09.2014, In: NEW ENGL J MED. 371, 10, p. 906-17 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  60. Lenalidomide in relapsed and refractory multiple myeloma disease: feasibility and benefits of long-term treatment

    Zago, M., Oehrlein, K., Rendl, C., Hahn-Ast, C., Kanz, L. & Weisel, K., 12.2014, In: ANN HEMATOL. 93, 12, p. 1993-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  61. 2015

  62. Health-related quality of life from the MM-003 trial of pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed and/or refractory multiple myeloma

    Song, K. W., Dimopoulos, M. A., Weisel, K. C., Moreau, P., Palumbo, A., Belch, A., Schey, S., Sonneveld, P., Sternas, L., Yu, X., Amatya, R., Monzini, M. S., Zaki, M., Jacques, C. & San Miguel, J., 02.2015, In: HAEMATOLOGICA. 100, 2, p. e63-7

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 3 4 5 Next